Pesquisas alternativas:
shame companies » share companies (Expandir a Pesquisa), some companies (Expandir a Pesquisa), state companies (Expandir a Pesquisa)
daily compared » early compared (Expandir a Pesquisa), elderly compared (Expandir a Pesquisa)
companies can » companies case (Expandir a Pesquisa), companies a (Expandir a Pesquisa), companies cut (Expandir a Pesquisa)
computers a » computers _ (Expandir a Pesquisa)
vi daily » i daily (Expandir a Pesquisa), ii daily (Expandir a Pesquisa), bmi daily (Expandir a Pesquisa)
j shame » j shane (Expandir a Pesquisa), j shape (Expandir a Pesquisa), j shale (Expandir a Pesquisa)
can now » can non (Expandir a Pesquisa), can new (Expandir a Pesquisa), can ngoc (Expandir a Pesquisa)
a now » a new (Expandir a Pesquisa), a non (Expandir a Pesquisa), _ now (Expandir a Pesquisa)
shame companies » share companies (Expandir a Pesquisa), some companies (Expandir a Pesquisa), state companies (Expandir a Pesquisa)
daily compared » early compared (Expandir a Pesquisa), elderly compared (Expandir a Pesquisa)
companies can » companies case (Expandir a Pesquisa), companies a (Expandir a Pesquisa), companies cut (Expandir a Pesquisa)
computers a » computers _ (Expandir a Pesquisa)
vi daily » i daily (Expandir a Pesquisa), ii daily (Expandir a Pesquisa), bmi daily (Expandir a Pesquisa)
j shame » j shane (Expandir a Pesquisa), j shape (Expandir a Pesquisa), j shale (Expandir a Pesquisa)
can now » can non (Expandir a Pesquisa), can new (Expandir a Pesquisa), can ngoc (Expandir a Pesquisa)
a now » a new (Expandir a Pesquisa), a non (Expandir a Pesquisa), _ now (Expandir a Pesquisa)
1
Por Feldman, Gregory J., Sousa, Ana R., Lipson, David A., Tombs, Lee, Barnes, Neil, Riley, John H., Patel, Sadhana, Naya, Ian, Compton, Chris, Alcázar Navarrete, Bernardino
Publicado no Adv Ther (2017)
“... corticosteroid therapy. Patients were randomized to receive UMEC/VI (62.5/25 µg once daily) via a multidose dry...”Publicado no Adv Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Zebardast, Nazlee, Swenor, Bonnielin K., van Landingham, Suzanne W., Massof, Robert W., Munoz, Beatriz, West, Sheila K., Ramulu, Pradeep Y.
Publicado no Ophthalmology (2015)
“... as reference, and 2) a one-line decrement in acuity due to VI or URE. MAIN OUTCOME MEASURES: Objective measures...”Publicado no Ophthalmology (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Stocker, Thomas J, Deseive, Simon, Leipsic, Jonathon, Hadamitzky, Martin, Chen, Marcus Y, Rubinshtein, Ronen, Heckner, Mathias, Bax, Jeroen J, Fang, Xiang-Ming, Grove, Erik Lerkevang, Lesser, John, Maurovich-Horvat, Pál, Otton, James, Shin, Sanghoon, Pontone, Gianluca, Marques, Hugo, Chow, Benjamin, Nomura, Cesar H, Tabbalat, Ramzi, Schmermund, Axel, Kang, Joon-Won, Naoum, Christopher, Atkins, Melany, Martuscelli, Eugenio, Massberg, Steffen, Hausleiter, Jörg
Publicado no Eur Heart J (2018)
“... undergoing cardiac CTA during one calendar month in 2017. Computed tomography angiography scan data...”Publicado no Eur Heart J (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Svedsater, Henrik, Stynes, Gillian, Wex, Jaro, Frith, Lucy, Leather, David, Castelnuovo, Emanuela, Detry, Michelle, Berry, Scott
Publicado no Asthma Res Pract (2016)
“...BACKGROUND: Fluticasone furoate (FF)/vilanterol (VI) is a once-daily inhaled corticosteroid (ICS...”Publicado no Asthma Res Pract (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Stynes, Gillian, Svedsater, Henrik, Wex, Jaro, Lettis, Sally, Leather, David, Castelnuovo, Emanuela, Detry, Michelle, Berry, Scott
Publicado no Respir Res (2015)
“...BACKGROUND: Fluticasone furoate (FF)/vilanterol (VI) 100/25 mcg is a once-daily inhaled...”Publicado no Respir Res (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Ryo Atsuta, Jun Takai, Isao Mukai, Akihiro Kobayashi, Takeo Ishii, Henrik Svedsater
Publicado em 2018-10-01
“... asthma patients, treatment with once-daily FF/VI was associated with higher medication adherence compared...”Publicado em 2018-10-01
Obter o texto integral
Artigo
7
Por O’Byrne, Paul M., Bleecker, Eugene R., Bateman, Eric D., Busse, William W., Woodcock, Ashley, Forth, Richard, Toler, William T., Jacques, Loretta, Lötvall, Jan
Publicado em 2014
“... objectives were to compare the efficacy and safety of once-daily FF/VI with FF alone and twice-daily...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Gary T. Ferguson, Nicola Brown, Chris Compton, Thomas C. Corbridge, Kelly Dorais, Charles Fogarty, Catherine Harvey, Morrys C. Kaisermann, David A. Lipson, Neil Martin, Frank Sciurba, Marjorie Stiegler, Chang-Qing Zhu, David Bernstein
Publicado em 2020-05-01
“... trials comparing once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) 100/62.5/25 μg via...”Publicado em 2020-05-01
Obter o texto integral
Artigo
9
Por Tabberer, Maggie, Lomas, David A., Birk, Ruby, Brealey, Noushin, Zhu, Chang-Qing, Pascoe, Steve, Locantore, Nicholas, Lipson, David A.
Publicado no Adv Ther (2018)
“..., double-blind, double-dummy, multicenter study comparing once-daily single inhaler triple therapy...”Publicado no Adv Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Yuan, Peiyan, Liu, Shuying, Lv, Yingtao, Liu, Weilong, Ma, Weiqun, Xu, Pingping
Publicado no Int J Nanomedicine (2019)
“...BACKGROUND: Dentin hypersensitivity is a common negative oral condition that can be treated...”Publicado no Int J Nanomedicine (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Bateman, Eric D, O'Byrne, Paul M, Busse, William W, Lötvall, Jan, Bleecker, Eugene R, Andersen, Leslie, Jacques, Loretta, Frith, Lucy, Lim, Jessica, Woodcock, Ashley
Publicado em 2014
“... of the addition of a novel LABA, vilanterol (VI), to a once-daily ICS, fluticasone furoate (FF), on the risk...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Bhatt, Surya P, Dransfield, Mark T, Cockcroft, John R, Wang-Jairaj, Jie, Midwinter, Dawn A, Rubin, David B, Scott-Wilson, Catherine A, Crim, Courtney
Publicado no Int J Chron Obstruct Pulmon Dis (2017)
“... [SE]) changes from baseline in aPWV were −1.75 m/s (SE =0.26, FF/VI), −1.95 m/s (SE =0.24, VI...”Publicado no Int J Chron Obstruct Pulmon Dis (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Zheng, Jinping, Zhong, Nanshan, Newlands, Amy, Church, Alison, Goh, Aik H
Publicado no Int J Chron Obstruct Pulmon Dis (2015)
“... in the US and EU. We compared the efficacy and safety of UMEC/VI with placebo in patients with COPD of Asian...”Publicado no Int J Chron Obstruct Pulmon Dis (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Lötvall, J, Bakke, P S, Bjermer, L, Steinshamn, S, Scott-Wilson, C, Crim, C, Sanford, L, Haumann, B
Publicado em 2012
“...BACKGROUND: Fluticasone furoate/vilanterol (FF/VI) is a novel once-daily (OD) inhaled...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Sliwka, Agnieszka, Jankowski, Milosz, Gross‐Sondej, Iwona, Storman, Monika, Nowobilski, Roman, Bala, Malgorzata M
Publicado no Cochrane Database Syst Rev (2018)
“... influence adherence. OBJECTIVES: To compare a once‐daily combination of inhaled corticosteroid and long...”Publicado no Cochrane Database Syst Rev (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Gill, Rupam, Poojar, Basavaraj, Bairy, Laxminarayana K., Praveen, Kumar S. E.
Publicado no J Pharm Bioallied Sci (2019)
“... activity inhibition is owed are methyl syringate (MSYR) and leptosin (a novel glycoside of MSYR). The non...”Publicado no J Pharm Bioallied Sci (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Albertson, Timothy E, Murin, Susan, Sutter, Mark E, Chenoweth, James A
Publicado no Pragmat Obs Res (2017)
“... and small RCTs, are supportive of the use of once-daily FF/VI in COPD maintenance therapy....”Publicado no Pragmat Obs Res (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Busse, William W, O'Byrne, Paul M, Bleecker, Eugene R, Lötvall, Jan, Woodcock, Ashley, Andersen, Leslie, Hicks, Wesley, Crawford, Jodie, Jacques, Loretta, Apoux, Ludovic, Bateman, Eric D
Publicado em 2013
“...: Patients (aged ≥12 years; on inhaled corticosteroid) were randomised (2:2:1) to FF/VI 100/25 µg or FF/VI...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Mortazavi, S. M. J., Rahimi, S., Mosleh-Shirazi, M. A., Arjomandi, M., Soleimani, A., Koohi Hossein-abadi, O., Haghani, M., Alavi, M.
Publicado no J Biomed Phys Eng (2015)
“... and Vit A. Group 4; all three vitamins. Group V; an over-the-counter multivitamin. Group VI; none...”Publicado no J Biomed Phys Eng (2015)
Obter o texto integral
Obter o texto integral
Artigo
20
Por Bremner, Peter R., Birk, Ruby, Brealey, Noushin, Ismaila, Afisi S., Zhu, Chang-Qing, Lipson, David A.
Publicado no Respir Res (2018)
“.../VI versus FF/VI + UMEC was 0.87 (95% CI 0.68, 1.12). The incidence of adverse events was comparable...”Publicado no Respir Res (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo